Organogenesis Holdings Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Organogenesis Holdings Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2015 to Q4 2024.
  • Organogenesis Holdings Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $7.67M.
  • Organogenesis Holdings Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $861K, a 82.6% decline year-over-year.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $861K, a 82.6% decline from 2023.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $4.95M, a 68.2% decline from 2022.
  • Organogenesis Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $15.5M, a 83.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $7.67M +$8.24M Dec 31, 2024 10-K 2025-02-27
Q3 2024 $12.3M +$9.16M +289% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$17M -$22.4M -421% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$2.1M +$869K +29.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$569K -$8.06M -108% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $3.17M +$2.95M +1373% Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $5.32M -$3.43M -39.2% Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2.97M -$2.06M -225% Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.49M -$43.5M -85.3% Dec 31, 2022 10-K 2025-02-27
Q3 2022 $215K -$12.4M -98.3% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $8.74M -$11.9M -57.7% Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$913K -$10.9M -109% Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $51M +$33M +184% Dec 31, 2021 10-K 2024-02-29
Q3 2021 $12.6M -$8.18M -39.4% Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $20.7M +$25.9M Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $9.94M +$26.3M Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $18M +$20.6M Dec 31, 2020 10-K 2023-03-01
Q3 2020 $20.8M +$31.5M Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$5.17M +$4.48M +46.5% Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$16.3M -$647K -4.13% Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$2.65M +$6.6M +71.3% Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$10.7M +$2.34M +17.9% Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$9.65M +$10.4M +51.8% Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$15.7M +$6.82M +30.3% Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$9.26M -$4.83M -109% Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$13.1M -$7.68M -142% Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$20M -$20M -64648% Jun 30, 2018 10-K 2019-03-18
Q1 2018 -$22.5M -$24.8M -1088% Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$4.43M -$4.25M -2385% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$5.4M -$5.39M Sep 30, 2017 10-K 2019-03-18
Q2 2017 $31K +$31.5K Jun 30, 2017 10-K 2019-03-18
Q1 2017 $2.28M +$2.29M Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$178K -$153K -608% Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$14.5K* Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$500* Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$15.6K* Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$25.2K Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.